Patents by Inventor Paul McGlynn

Paul McGlynn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180222845
    Abstract: Levalbuterol L-tartrate affords crystals possessing properties desirable for use in a metered dose inhaler.
    Type: Application
    Filed: October 18, 2017
    Publication date: August 9, 2018
    Inventors: Paul McGlynn, Roger BAKALE, Craig STURGE
  • Publication number: 20160368858
    Abstract: Levalbuterol L-tartrate affords crystals possessing properties desirable for use in a metered dose inhaler.
    Type: Application
    Filed: January 22, 2016
    Publication date: December 22, 2016
    Inventors: Paul McGlynn, Roger Bakale, Craig Sturge
  • Patent number: 9499476
    Abstract: The compound of formula (I) is a water-stable, long acting ?2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like. Processes for making the compound of formula (I), as well as related intermediates, are disclosed.
    Type: Grant
    Filed: April 22, 2015
    Date of Patent: November 22, 2016
    Assignee: SUNOVION PHARMACEUTICALS INC.
    Inventors: Craig R. Abolin, H. Scott Wilkinson, Paul McGlynn, William K. McVicar
  • Publication number: 20150225334
    Abstract: The compound of formula (I) is a water-stable, long acting ?2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like. Processes for making the compound of formula (I), as well as related intermediates, are disclosed.
    Type: Application
    Filed: April 22, 2015
    Publication date: August 13, 2015
    Applicant: SUNOVION PHARMACEUTICALS INC.
    Inventors: Craig R. ABOLIN, H. Scott WILKINSON, Paul MCGLYNN, William K. MCVICAR
  • Patent number: 9040588
    Abstract: The compound of formula (I) is a water-stable, long acting ?2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like. Processes for making the compound of formula (I), as well as related intermediates, are disclosed.
    Type: Grant
    Filed: January 17, 2014
    Date of Patent: May 26, 2015
    Assignee: SUNOVION PHARMACEUTICALS INC.
    Inventors: Craig R. Abolin, H. Scott Wilkinson, Paul McGlynn, William K. McVicar
  • Publication number: 20150071969
    Abstract: Levalbuterol L-tartrate affords crystals possessing properties desirable for use in a metered dose inhaler.
    Type: Application
    Filed: May 21, 2014
    Publication date: March 12, 2015
    Applicant: SUNOVION PHARMACEUTICALS INC.
    Inventors: Paul MCGLYNN, Roger Bakale, Craig Sturge
  • Publication number: 20140336218
    Abstract: Compositions and methods for the prevention and/or treatment of airway and/or respiratory disorders are provided. The compositions comprise arformoterol (the (R,R)-formoterol isomer) and tiotropium.
    Type: Application
    Filed: July 25, 2014
    Publication date: November 13, 2014
    Applicant: SUNOVION PHARMACEUTICALS INC.
    Inventors: Holly HUANG, Elizabeth B. GOODWIN, Kendyl M. SCHAEFER, John P. HANRAHAN, William T. ANDREWS, Paul MCGLYNN
  • Patent number: 8856854
    Abstract: A processor for a cable television set-top box has an interface for coupling the processor to a second processor. The processor also has a port that is coupleable to control a tuner, a demodulator and a DOCSIS module with or without DSG support. The tuner has an output coupled to the demodulator input, and the demodulator has an output to the DOCSIS module input. The demodulator's output is also coupled to a conditional access module controlled by the second processor. The processor issues commands via the port to control at least one of the tuner and the demodulator based on instructions received via the interface from the second processor.
    Type: Grant
    Filed: January 18, 2013
    Date of Patent: October 7, 2014
    Assignee: Broadcom Corporation
    Inventors: Weimin Feng, Paul McGlynn, David Lwin, David Erickson, Haisong Wang
  • Patent number: 8765153
    Abstract: Levalbuterol L-tartrate affords crystals possessing properties desirable for use in a metered dose inhaler.
    Type: Grant
    Filed: April 29, 2013
    Date of Patent: July 1, 2014
    Inventors: Paul McGlynn, Roger Bakale, Craig Sturge
  • Publication number: 20140170081
    Abstract: The inventive subject matter relates to a pharmaceutical aerosol product suitable for administration by oral or nasal inhalation and its use in the treatment of respiratory diseases, in particular in the treatment of children.
    Type: Application
    Filed: August 13, 2012
    Publication date: June 19, 2014
    Inventors: Helgert Muller, Renate Engelstatter, Ulrich Bildmann, Andrea Bauer, Paul Mcglynn
  • Publication number: 20140135300
    Abstract: The compound of formula (I) is a water-stable, long acting ?2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like. Processes for making the compound of formula (I), as well as related intermediates, are disclosed.
    Type: Application
    Filed: January 17, 2014
    Publication date: May 15, 2014
    Applicant: SUNOVION PHARMACEUTICALS INC.
    Inventors: Craig R. Abolin, H. Scott Wilkinson, Paul McGlynn, William K. McVicar
  • Patent number: 8664441
    Abstract: The compound of formula (I) is a water-stable, long acting ?2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like. Processes for making the compound of formula (I), as well as related intermediates, are disclosed.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: March 4, 2014
    Assignee: Sunovion Pharmaceuticals Inc.
    Inventors: Craig R. Abolin, H. Scott Wilkinson, Paul McGlynn, William K. McVicar
  • Publication number: 20130296607
    Abstract: The compound of formula (I) is a water-stable, long acting ?2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like. Processes for making the compound of formula (I), as well as related intermediates, are disclosed.
    Type: Application
    Filed: July 3, 2013
    Publication date: November 7, 2013
    Inventors: Craig R. Abolin, H. Scott Wilkinson, Paul McGlynn, William K. McVicar
  • Publication number: 20130236515
    Abstract: Levalbuterol L-tartrate affords crystals possessing properties desirable for use in a metered dose inhaler.
    Type: Application
    Filed: April 29, 2013
    Publication date: September 12, 2013
    Applicant: Sunovion Pharmaceuticals Inc.
    Inventors: Paul MCGLYNN, Roger BAKALE, Craig STURGE
  • Patent number: 8501994
    Abstract: The compound of formula (I) is a water-stable, long acting ?2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: August 6, 2013
    Assignee: Sunovion Pharmaceuticals Inc.
    Inventors: Craig R. Abolin, H. Scott Wilkinson, Paul McGlynn, William K. McVicar
  • Publication number: 20130028845
    Abstract: Levalbuterol L-tartrate affords crystals possessing properties desirable for use in a metered dose inhaler.
    Type: Application
    Filed: October 2, 2012
    Publication date: January 31, 2013
    Applicant: Sunovion Pharmaceuticals Inc.
    Inventors: Paul McGlynn, Roger Bakale, Craig Sturge
  • Patent number: 8359624
    Abstract: A processor for a cable television set-top box has an interface for coupling the processor to a second processor. The processor also has a port that is coupleable to control a tuner, a demodulator and a DOCSIS module with or without DSG support. The tuner has an output coupled to the demodulator input, and the demodulator has an output to the DOCSIS module input. The demodulator's output is also coupled to a conditional access module controlled by the second processor. The processor issues commands via the port to control at least one of the tuner and the demodulator based on instructions received via the interface from the second processor.
    Type: Grant
    Filed: February 26, 2007
    Date of Patent: January 22, 2013
    Assignee: Broadcom Corporation
    Inventors: Weimin Feng, Paul McGlynn, David Leo Lwin, David Martin Erickson, Haisong Wang
  • Patent number: 8173829
    Abstract: The compound of formula (I) is a water-stable, long acting ?2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like.
    Type: Grant
    Filed: March 31, 2010
    Date of Patent: May 8, 2012
    Assignee: Sunovion Pharmaceuticals Inc.
    Inventors: Craig R. Abolin, H. Scott Wilkinson, Paul McGlynn, William K. McVicar
  • Publication number: 20110250242
    Abstract: Compositions and methods for the prevention and/or treatment of airway and/or respiratory disorders are provided. The compositions comprise arformoterol (the (R,R)-formoterol isomer) and tiotropium.
    Type: Application
    Filed: October 22, 2009
    Publication date: October 13, 2011
    Applicant: SUNOVION PHARMACEUTICALS INC.
    Inventors: Holly Huang, Elizabeth B. Goodwin, Kendyl M. Schaefer, John P. Hanrahan, William T. Andrews, Paul Mcglynn
  • Publication number: 20100272654
    Abstract: Levalbuterol L-tartrate affords crystals possessing properties desirable for use in a metered dose inhaler.
    Type: Application
    Filed: July 9, 2010
    Publication date: October 28, 2010
    Inventors: Paul McGlynn, Roger Bakale, Craig Sturge